OnKure Therapeutics (OKUR) Share-based Compensation (IS) (2024 - 2025)
OnKure Therapeutics' Share-based Compensation (IS) was $11.63 million in FY2025, up 156.8% from $4.53 million in FY2024.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Share-based Compensation (IS) (2024 - 2025) Analysis & Trends
- Per Business Quant data, Share-based Compensation (IS) in earlier years was $4.53 million in FY2024 and $199,000 in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | - |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | - |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | - |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | - |
| 10 | OnKure Therapeutics | 114.95 Mn | -382.97 Mn | - | - |
API Access
OnKure Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();